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LIVER AND BILIARY DISEASE
Prospective comparative study of spiral computer
tomography and magnetic resonance imaging for
detection of hepatocellular carcinoma
J Stoker, M G Romijn, R A de Man, J T Brouwer, G J Weverling, J M van Muiswinkel,
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Background: Hepatocellular carcinoma (HCC) is often detected at a relatively late stage when tumour
size prohibits curative surgery. Screening to detect HCC at an early stage is performed for patients at
risk.
Aim: The aim of this study was to compare prospectively the diagnostic accuracy and classification for
management of the two state of the art secondline imaging techniques: triphasic spiral computer tom-
ography (CT) and super paramagnetic iron oxide (SPIO) enhanced magnetic resonance imaging (MRI).
Patients: Sixty one patients were evaluated between January 1996 and January 1998. Patients
underwent CT and MRI within a mean interval of 6.75 days.
Methods: CT and MRI were evaluated blindly for the presence and number of lesions, character-
isation of these lesions, and classification for management. For comparison of the data on characteri-
sation, the CT and MRI findings were compared with histopathological studies of the surgical
specimens and/or follow up imaging. Data of patients not lost to follow up were available to January
2001.
Results: SPIO enhanced MRI detected more lesions and overall smaller lesions than triphasic spiral CT
(number of lesions 189 v 124; median diameter 1.0 v 1.8 cm; Spearman rank’s correlation coefficient
0.63, p<0.001). There was no significant difference in accuracy between CT and MRI for lesion char-
acterisation. The agreement in classification for management was very good (weighted kappa 0.91,
95% CI 0.83–0.99).
Conclusion: SPIO enhanced MRI detects more and smaller lesions, but both techniques are compar-
able in terms of classification for management. SPIO enhanced MRI may be preferred as there is no
exposure to ionising radiation.
Secondline imaging is performed in patients positive inscreening programmes for hepatocellular carcinoma(HCC) to detect and characterise intrahepatic lesions.
Recent developments in computer tomography (CT) and
magnetic resonance imaging (MRI) techniques have led to
several new strategies for advanced imaging but the optimum
strategy has not yet been established.
The aim of this prospective study was to compare triphasic
spiral CT and super paramagnetic iron oxide (SPIO) enhanced
MRI in establishing the number of hepatic lesions and their
nature and to compare both techniques in terms of
classification for management (surgery) in patients suspected
of having HCC at screening.
MATERIAL AND METHODS
Patient inclusion
From January 1996 to January 1998, we studied 61
consecutive patients (41 males, 20 females; mean age 54.4
years, range 30–77). Patients were included in the present
study when at screening a new non-cystic focal lesion was
detected at ultrasound and/or α fetoprotein (AFP) level was
elevated to twice the previous value or twice the upper limit of
normal (20 µg/l). Patients were excluded when there were
contraindications for intravenous low osmolar iodised con-
trast medium, SPIO, or MRI. For 36 patients, findings at imag-
ing were compared with histopathological findings on the
resected specimen or follow up imaging.
Imaging and image analysis
Spiral CT comprised plain, arterial phase, and portal phase
imaging using a single detector row machine. For analysis of
the MRI, the most sensitive sequence was used: axial T2w
turbo spin echo (TSE) with fat saturation after administration
of SPIO. CT and MRI were evaluated blindly and separately by
two consultants. Triphasic spiral CT and MRI with SPIO were
evaluated for the presence of hepatic lesions, number of
hepatic lesions, size of the lesions (<2 cm, 2–<5 cm,>5 cm),
diagnosis of the lesions (for a maximum of three lesions), and
for establishing the correct classification for management.
CT and MRI were compared for establishing the correct
classification for management: no suspect lesion and no
surgical treatment; suspect lesion(s) and eligible for curative
surgery; and extensive disease without the possibility of cura-
tive surgical treatment. Patients with a suspect lesion(s) for
HCC were considered candidates for hepatic surgery when
only one lesion was present (<5 cm) or there were two lesions
of <2 cm.
Histopathology and follow up imaging
Histopathological studies were evaluated with knowledge of
the findings at spiral CT and MRI with SPIO. Follow up imag-
ing comprised repeat triphasic CT andMRI with SPIO. Growth
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Abbreviations: AFP, α fetoprotein; CT, computer tomography; HCC,
hepatocellular carcinoma; MRI, magnetic resonance imaging; SPIO,
super paramagnetic iron oxide; TSE, turbo spin echo.
See end of article for
authors’ affiliations
. . . . . . . . . . . . . . . . . . . . . . .
Correspondence to:
Dr J Stoker, Department of
Radiology, Academic
Medical Centre, University
of Amsterdam, PO Box
22700, 1100 DE
Amsterdam, the
Netherlands;
j.stoker@amc.uva.nl
Accepted for publication
11 September 2001
. . . . . . . . . . . . . . . . . . . . . . .
105
www.gutjnl.com
 on 15 November 2006 gut.bmj.comDownloaded from 
of lesions by at least 20% of the initial diameter or 5 mm or
more and/or the presence of new lesions was defined as
evidence of malignancy.
Statistical analysis
Statistical analysis was performed with SAS version 6.12 (SAS
Institute Inc., Cary, North Carolina, USA). The number of
lesions per patient at CT and MRI were compared using the
Wilcoxon rank’s sum test. Correlation of CT andMRI for lesion
size was determined using Spearman rank’s correlation test.
p<0.05 was considered significant. Weighted kappa values
were calculated for agreement between CT and MRI in terms
of classification for management.
RESULTS
Two patients experienced uneventful back pain during the
SPIO infusion for MRI. One patient suffered transient
hypotension after the SPIO infusion for follow upMRI but did
not require further treatment.
For the 61 patients studied, SPIO enhanced MRI detected
more HCC suspect lesions than triphasic spiral CT (124 v 189).
The total number of suspect lesions identified with CT or MRI
was 197 (table 1). Median number of lesions was 1
(interquartile range 1–3.5) at CT and 2 (interquartile range
1–7) at MRI. In 39 patients equal numbers of lesions were
found, in five patients more lesions were found with CT, and in
18 patients more lesions were found by MRI, indicating that
MRI detected more lesions compared with CT scan (p<0.01).
In 14 of 15 patients diagnosed with cirrhosis at histopathol-
ogy, MRI and CT scan showed equal numbers of lesions.
Median diameter of the lesions at MRI was smaller (1.0 cm;
interquartile range 1.0–2.5 cm) than at CT (1.8 cm; interquar-
tile range 1.0–4.0 cm) (Spearman rank’s correlation coefficient
0.63, p<0.001) (fig 1). When only the largest lesion was con-
sidered per patient, median diameter was 5.4 cm (interquar-
tile range 2.7–9.8) for CT and 5.6 cm (interquartile range 2.4–
8.4) for MRI.
CT and MRI had very good agreement (weighted kappa
0.91; 95% confidence intervals 0.83–0.99) in classifying
patients for management (table 2). In five patients there were
differences in classification for management; in all, MRI was
correct.
For the 36 patients with positive histopathological findings
for the partial or completely resected liver and follow up
imaging, findings of CT and MRI in characterizing the lesions
were comparable (table 3).
For the 10 patients who underwent liver transplantation, CT
yielded the correct number of lesions and correct characterisa-
tion of the lesions in six cases (MRI in nine cases). For the six
patients with a resected liver, CT findings were correct in five
cases and MRI findings were correct in all cases. With CT, a 3
cm HCC was missed.
DISCUSSION
The present prospective study demonstrated that SPIO
enhanced MRI was superior to spiral CT for detection of
lesions in patients at risk of HCC. A major problem is differen-
tiation between benign nodules (regenerative nodules and
dysplastic nodules) and HCC in cirrhotic livers. MRI has been
advocated as the optimum imaging technique for differentia-
tion between these benign nodules and HCC, with further
improvement with the use of SPIO.1–3 The limiting factor is the
gradual progression of dysplastic nodules to HCC, which is
only partly reflected in changes in the imaging characteristics.
Normal liver parenchyma, regenerative nodules, and dysplas-
tic nodules demonstrate uptake of SPIO by Kupffer cells but
this may also be found in highly differentiated HCC.
Therefore, some highly differentiated lesions may be consid-
ered benign lesions.
Importantly, the detection of more lesions at MRI compared
with CT in this study did not lead to improved classification for
treatment (for example, curative surgery). The major reason is
that the difference in detection of lesions is predominantly in
patients with extensive disease (more than two lesions). These
patients are not candidates for curative surgery and therefore
differences in the number of lesions higher than two do not
influence management.
Both spiral CT and MRI are rapidly developing techniques
with new improvements yet to come. For MRI the widespread
use of phased array coils, new imaging sequences, and proto-
cols (for example, multiphase breath hold three dimensional
gadolinium enhanced MR) and further developments in liver
specific contrast media will enhance the efficacy of the
technique. A recent innovation is the introduction of the next
generation of CT scanners with the possibility of very thin
slices (1–3 mm), which might improve lesion detection with
Table 1 Number of suspected lesions at triphasic
spiral computer tomography (CT) and super
paramagnetic iron oxide enhanced magnetic
resonance imaging (MRI) in 61 patients
MRI
<2 cm 2–<5 cm >5 cm All
CT
<2 cm 128 10 2 140
2–<5 cm 9 19 2 30
>5 cm 2 1 24 27
All 139 30 28 197
Figure 1 Diameter of the lesions measured by spiral computer
tomography (CT) scan or magnetic resonance imaging (MRI) in 61
patients. The broken line represents the x=y line.
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Table 2 Agreement in terms of classification for
management by computer tomography (CT) or
magnetic resonance imaging (MRI) in 61 patients.
MRI
No
surgery
necessary
Eligible
for
surgery
Extensive
disease, no
surgery
CT
No surgery necessary 15 2 0
Eligible for surgery 1 7 2
Extensive disease, no
surgery
0 0 34
Weighted kappa 0.91 (95% confidence interval 0.83–0.99).
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spiral CT. A drawback is the further increase in radiation dose,
especially for patients who need multiple secondline imaging
procedures during the screening period. The CT technique
used in the present study produces an effective dose of
approximately 12 mSv, leading to an estimated risk of a fatal
radiation induced cancer of 1:1700 per examination for the
general population.4 5 This risk, which is age dependent,
decreases with increasing age.
Triphasic spiral CT and SPIO enhanced MRI are both valu-
able advanced imaging techniques but the absence of ionising
radiation exposure makes SPIO enhanced MRI preferable for
the workup and follow up of patients suspected of having
HCC. As a result, future studies on HCC may become more
accurate in the identification and monitoring of this
malignancy.
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Table 3 Characterisation of liver lesions (maximum three per patient) detected with triphasic spiral computer
tomography (CT) and super paramagnetic iron oxide (SPIO) enhanced magnetic resonance imaging (MRI) in 36 patients
compared with histopathology and/or follow up imaging
Triphasic spiral CT SPIO enhanced MRI
Histopathology/ follow up
imaging
HCC 20 (16) 25 (18) 25
Regeneration nodule* 1 (1) 4 (4) 5
Benign lesion (cyst, haemangioma) 14 (13) 15 (14) 18
Metastasis 0 0 3
*Lesions characterised as suspect lesion at screening ultrasound.
Numbers in parentheses are correctly characterised lesions.
HCC, hepatocellular carcinoma.
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